Glycated haemoglobin (HbA1c) has transformed how we diagnose and manage diabetes. Unlike a fasting glucose, which shows your blood sugar at a single moment, HbA1c reflects your average blood glucose level over the past 2โ3 months. This makes it the gold standard for monitoring long-term glucose control.
How HbA1c Works
Glucose in the blood naturally attaches to haemoglobin in red blood cells โ a process called glycation. The higher your blood sugar, the more glucose attaches. Since red blood cells live for about 90โ120 days, HbA1c gives a reliable average over that period. The result is reported as a percentage of total haemoglobin that is glycated.
Interpreting Your HbA1c
The American Diabetes Association (ADA) and WHO use the following cut-points:
- < 5.7% (< 39 mmol/mol): Normal โ not diabetes
- 5.7โ6.4% (39โ47 mmol/mol): Pre-diabetes โ increased risk
- โฅ 6.5% (โฅ 48 mmol/mol): Diabetes โ on two separate tests
- < 7.0%: Recommended target for most adults with diabetes
- < 8.0%: Acceptable target for elderly or those with hypoglycaemia risk
A single HbA1c โฅ 6.5% is sufficient to diagnose diabetes in a symptomatic patient. In asymptomatic patients, two abnormal results (HbA1c, fasting glucose, or oral glucose tolerance) are required.
HbA1c and Average Blood Glucose
The Estimated Average Glucose (eAG) formula converts HbA1c to an average blood glucose value that patients find more intuitive. Roughly: HbA1c 6% โ 126 mg/dL, 7% โ 154 mg/dL, 8% โ 183 mg/dL, 9% โ 212 mg/dL, 10% โ 240 mg/dL.
Limitations of HbA1c
HbA1c can be falsely low in conditions where red cell lifespan is shortened (haemolytic anaemia, recent blood transfusion) and falsely high in iron deficiency anaemia. In these situations, fasting glucose or continuous glucose monitoring may be more reliable.
- Haemoglobin variants (HbS, HbC, HbE) can interfere with some HbA1c assays
- Results may vary slightly between laboratories
- Always interpret alongside fasting glucose and symptoms
References & Sources
Medical Advisory
Expert oversight & content review
Dr. Naeem Mahmood Ashraf
PhD Biochemistry & Biotechnology
University of Punjab, Lahore
Dr. Naeem Mahmood Ashraf is a distinguished biochemist and biotechnologist at the University of Punjab, Lahore, Pakistan. With a PhD in Biochemistry & Biotechnology and over 45 peer-reviewed publications (h-index: 10), Dr. Ashraf brings deep expertise in clinical biochemistry, genomics, and computational biology to LabSense AI. His research bridges laboratory science and patient care, ensuring all interpretations follow WHO, IFCC, and AACC international standards.
Credentials
Areas of Expertise
